| Name | Title | Contact Details |
|---|
QuVa Pharma, Inc. is a newly-formed national platform for sterile compounding pharmacy services led by two experienced industry executives that has received a majority equity commitment from Bain Capital Private Equity to support the company’s creation and expansion plans. As part of its formation, QuVa Pharma has acquired the assets of the compounding services division of a company leader in the field of parenteral and management services, including its state-of-the-art 503B manufacturing facility in Sugar Land, Texas.
ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.
Eleme Medical is a Merrimack, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nikon Instruments is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lasik Vision Institute is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Palm Springs, FL. To find more information about Lasik Vision Institute, please visit www.lasikvisioninstitute.com